➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

Triamcinolone - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for triamcinolone and what is the scope of patent protection?

Triamcinolone is the generic ingredient in thirty branded drugs marketed by Astellas, Delcor Asset Corp, Barr, Impax Labs, Ivax Sub Teva Pharms, Mylan, Purepac Pharm, Roxane, Sandoz, Teva, Watson Labs, Abbvie, Sanofi Aventis Us, Ivax Pharms, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Cosette, Fougera Pharms, Glenmark Pharms Ltd, Lupin, Macleods Pharms Ltd, Morton Grove, Perrigo New York, Pharmaderm, Pharmafair, Saptalis Pharms, Strides Pharma, Taro, Taro Pharm Inds Ltd, Teligent, Topiderm, Crown Labs, Savage Labs, Flexion Theraps Inc, Apothecon, Amneal, Parnell, Sandoz Inc, Teva Pharms Usa, Allergan, Novartis, Akorn, Quagen, Wockhardt Bio Ag, Cintex Svcs, Encube, Glenmark Pharms, Novel Labs Inc, Perrigo Israel, Cmp Pharma Inc, Lyne, Lupin Atlantis, Sun Pharm Inds Inc, Perrigo Uk Finco, Rising, and Fosun Pharma, and is included in one hundred and fifty-nine NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifty-one drug master file entries for triamcinolone.

Drug Prices for triamcinolone

See drug prices for triamcinolone

Drug Sales Revenue Trends for triamcinolone

See drug sales revenues for triamcinolone

Recent Clinical Trials for triamcinolone

Identify potential brand extensions & 505(b)(2) entrants

Ottawa Hospital Research InstitutePhase 4
Our Lady of the Lake HospitalN/A
Louisiana State University Health Sciences Center in New OrleansN/A

See all triamcinolone clinical trials

Medical Subject Heading (MeSH) Categories for triamcinolone

US Patents and Regulatory Information for triamcinolone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 207651-002 Dec 26, 2017 AT RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Encube TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 212384-001 Nov 29, 2019 AT RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Wockhardt Bio Ag TRIAMCINOLONE ACETONIDE triamcinolone acetonide LOTION;TOPICAL 088450-001 Apr 1, 1985 AT RX No Yes   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.